| Element List | Explanation |
|---|---|
| Announcement Detail | Referring to the results of the regular general assembly meeting of Mouwasat Medical Services Co., held on 13 Jumada Thani 1447 corresponding to 04 December 2025, in which the members of the Board of Directors were elected for its new term, which begins on 04 January 2026 and lasts four years, ending on 03 January 2030 . The company announces the Board of Directors' decisions dated Sunday, Rajab 15, 1447 , corresponding to January 4, 2026 , as follows: First) Appointing Mr. Mohammad Sultan Al Subaie (non-executive member) as Chairman of the Board of Directors. Second) Appointment of Mr. Nassir Sultan Al Subaei (Executive Member) as Vice Chairman of the Board of Directors and CEO. Third) Appointing Mr. Khalid Suliman Al Saleem (Executive Member) as Managing Director. Fourth) Formation of the Executive Committee with the membership of: 1- Mr. Nassir Sultan Al Subaei - Executive Board Member - (Chairman of the Committee). 2- Mr. Khalid Suliman Al Saleem - Executive Board Member - (Committee Member). 3- Dr. Sami Abdulkarim Abdullah Alabdulkarim - Non-Executive Board Member - (Committee Member). 4- Mr. Ibrahim Hamad Ababtain - Independent Board Member - (Committee Member). Fifth) Formation of the Nominations and Remuneration Committee with the membership of: 1- Dr. Mohammed Hamad Rashed Alkathiri - Independent Board Member - (Chairman of the Committee). 2- Dr. Sami Abdulkarim Abdullah Alabdulkarim - Non-Executive Board Member - (Committee Member). 3- Mr. Fahad Ayed Saleh Alaslami - Independent Board Member - (Committee Member). Sixth) Appointment of Mr. Adel Fayez Ahmed Abou Hamra as Secretary of the Board of Directors. Seventh) Appointing Mr. Khalid Suliman Al Saleem (Managing Director) and Mr. Ahmed Mustafa Radwan to be the company's representatives to the Capital Market Authority, Tadawul Group and the Securities Depository Center Company for all purposes related to the implementation of the Capital Market System and its executive regulations. The audit committee was also formed pursuant to the same decision and will be disclosed separately in accordance with regulatory requirements |